West Pharmaceutical
249 hedge funds and large institutions have $4.06B invested in West Pharmaceutical in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 81 increasing their positions, 101 reducing their positions, and 18 closing their positions.
28% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 18
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
11% more capital invested
Capital invested by funds: $3.66B → $4.06B (+$400M)
0% more funds holding
Funds holding: 248 → 249 (+1)
0.39% less ownership
Funds ownership: 93.87% → 93.48% (-0.39%)
20% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 101
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.9M |
| 2 |
Select Equity Group
New York
|
+$25.8M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$19.3M |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.5M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$29.7M |
| 2 |
Neuberger Berman Group
New York
|
-$24.7M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$20.8M |
| 4 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$12.4M |
| 5 |
JP Morgan Chase
New York
|
-$9.23M |
WST Hedge Fund Activity: Q4 2015 in Review
249 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2015, worth a combined $4.06B — up 11% from $3.66B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new WST positions and 18 closed out — a net gain of 5 holders — while 81 added to existing stakes and 101 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $38.9M. The largest seller was Boston Trust Walden, cutting an estimated $29.7M.
- 249 institutional investors held West Pharmaceutical (WST) as of Q4 2015, up from 248 in Q3 2015.
- Funds reported $4.06B of West Pharmaceutical stock for Q4 2015, up 11% quarter-over-quarter.
- 23 funds opened new West Pharmaceutical positions in Q4 2015 and 18 closed out, a net change of +5 holders.
- The largest West Pharmaceutical buyer in Q4 2015 was T. Rowe Price Associates, an estimated $38.9M added.
- The largest West Pharmaceutical seller in Q4 2015 was Boston Trust Walden, an estimated $29.7M sold.
Based on aggregated 13F filings for Q4 2015.